Elucid Overview

  • Status
  • Private

  • Employees
  • 95

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5M

  • Investors
  • 19

Elucid General Information

Description

Developer of imaging system designed to improve patient outcomes at a reduced cost by applying artificial intelligence to vacsular diagnostic imaging. The company's system objectively quantifies the extent and stability of arterial plaque and offers an economically efficient and non-invasive method for capturing patient health information, enabling cardiovascular pathologists to enhance their patient care and provide comprehensive and accurate clinical insights.

Contact Information

Website
www.elucid.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2 Park Plaza
  • Suite 700
  • Boston, MA 02116
  • United States
+1 (617)
Primary Industry
Decision/Risk Analysis
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 2 Park Plaza
  • Suite 700
  • Boston, MA 02116
  • United States
+1 (617)

Elucid Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Elucid Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC $5M Completed Generating Revenue
9. Later Stage VC (Series C) 18-Oct-2023 Completed Generating Revenue
8. Later Stage VC (Series B) 28-Mar-2023 Completed Generating Revenue
7. Later Stage VC (Series A) 18-Dec-2020 Completed Generating Revenue
6. Later Stage VC (Series A) 10-Dec-2020 Completed Generating Revenue
5. Grant 01-Jun-2019 Completed Generating Revenue
4. Later Stage VC (Series B) 22-Feb-2019 Completed Startup
3. Grant 01-Jan-2015 Completed Startup
2. Early Stage VC (Series A) 31-Dec-2013 $375K $375K Completed Startup
1. Grant 01-Aug-2013 $3M Completed Startup
To view Elucid’s complete valuation and funding history, request access »

Elucid Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C
Series B-2
Series B-1
Series A4
Series A3
Series A2 2,319,244 $0.000100 $1.1 $1.1 1x $1.1 2.57%
Series A1 2,534,907 $0.000100 $0.71 $0.71 1x $0.71 2.81%
To view Elucid’s complete cap table history, request access »

Elucid Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of imaging system designed to improve patient outcomes at a reduced cost by applying artificial intelligence t
Decision/Risk Analysis
Boston, MA
95 As of 2024

Tel Aviv, Israel
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Elucid Competitors (32)

One of Elucid’s 32 competitors is Aidoc, a Venture Capital-Backed company based in Tel Aviv, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aidoc Venture Capital-Backed Tel Aviv, Israel
Arterys Formerly VC-backed San Francisco, CA
HeartFlow Venture Capital-Backed Mountain View, CA
ImmersiveTouch Venture Capital-Backed Chicago, IL
MedyMatch Technology Venture Capital-Backed Tel Aviv, Israel
You’re viewing 5 of 32 competitors. Get the full list »

Elucid Patents

  • 107

    Total Documents Applications and Grants

  • Total Patents Families

  • 76

    Granted

  • 29

    Pending

  • Expiring in next 12 mo

Elucid Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240153252-A1 Structured representations for interpretable machine learning applications in medical imaging Active 09-Nov-2022
US-12154321-B2 Structured representations for interpretable machine learning applications in medical imaging Active 09-Nov-2022
US-20230290433-A1 Virtual transcriptomics Pending 11-Mar-2022
US-20220415519-A1 Systems and methods for patient-specific therapeutic recommendations for cardiovascular disease Pending 10-Jun-2021
US-20220406459-A1 Systems and methods for clinical decision support for lipid-lowering therapies for cardiovascular disease Active 10-Jun-2021 A61B6/5217
To view Elucid’s complete patent history, request access »

Elucid Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Elucid Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
Elevage Medical Technologies PE-Backed Company Minority
Unorthodox Ventures Venture Capital Minority
Aphelion Capital Venture Capital Minority
Biovision Ventures Venture Capital Minority
Philips Ventures Corporate Venture Capital Minority
You’re viewing 5 of 19 investors. Get the full list »

Ready to get started?

Request a free trial

Elucid FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »